Covered recipient · General Payments record
ERIC JAMES REGELE
Allopathic & Osteopathic Physicians Urology
General Payments · PY2021–2024
$3,024.43
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,275.10 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| COLOPLAST CORP | $280.15 | 3 |
| Ambu Inc. | $225.98 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $188.95 | 2 |
| C. R. BARD, INC. & SUBSIDIARIES | $185.00 | 2 |
| Ferring Pharmaceuticals Inc. | $135.00 | 1 |
| Cook Medical LLC | $116.28 | 2 |
| DAVOL INC. | $70.11 | 1 |
| Teleflex LLC | $31.29 | 1 |
| BIOPROTECT MEDICAL, INC. | $25.78 | 1 |
| UROGEN PHARMA, INC. | $16.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Ambu Inc. | $38.79 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134081908 | CMS |
| Ambu Inc. | $64.59 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134082264 | CMS |
| Ambu Inc. | $122.60 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134082690 | CMS |
| BIOPROTECT MEDICAL, INC. | $25.78 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154296573 | CMS |
| Boston Scientific Corporation | $148.16 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092411246 | CMS |
| Boston Scientific Corporation | $40.79 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092411244 | CMS |
| C. R. Bard, Inc. & Subsidiaries | $92.02 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130836790 | CMS |
| C. R. Bard, Inc. & Subsidiaries | $92.98 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130836792 | CMS |
| COLOPLAST CORP | $54.23 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117462317 | CMS |
| COLOPLAST CORP | $168.08 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117462329 | CMS |
| COLOPLAST CORP | $57.84 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117462377 | CMS |
| Cook Medical LLC | $14.88 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118336827 | CMS |
| Cook Medical LLC | $101.40 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118332817 | CMS |
| Davol Inc. | $70.11 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127654794 | CMS |
| Ferring Pharmaceuticals Inc. | $135.00 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137504984 | CMS |
| Teleflex LLC | $31.29 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142098117 | CMS |
| UROGEN PHARMA, INC. | $16.56 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137931136 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.